Neuroprotection by the Ketogenic Diet: Evidence and Controversies

The ketogenic diet (KD) is a high-fat low-carbohydrate diet that has been used for decades as a non-pharmacologic approach to treat metabolic disorders and refractory pediatric epilepsy. In recent years, enthusiasm for the KD has increased in the scientific community due to evidence that the diet reduces pathology and improves various outcome measures in animal models of neurodegenerative disorders, including multiple sclerosis, stroke, glaucoma, spinal cord injury, retinal degenerations, Parkinson's disease and Alzheimer's disease. Clinical trials also suggest that the KD improved quality of life in patients with multiple sclerosis and Alzheimer's disease. Furthermore, the major ketone bodies BHB and ACA have potential neuroprotective properties and are now known to have direct effects on specific inflammatory proteins, transcription factors, reactive oxygen species, mitochondria, epigenetic modifications and the composition of the gut microbiome. Neuroprotective benefits of the KD are likely due to a combination of these cellular processes and other potential mechanisms that are yet to be confirmed experimentally. This review provides a comprehensive summary of current evidence for the effectiveness of the KD in humans and preclinical models of various neurological disorders, describes molecular mechanisms that may contribute to its beneficial effects, and highlights key controversies and current gaps in knowledge.

Automated summary

The ketogenic diet is a high-fat low-carbohydrate diet that has been used for decades to treat metabolic disorders and refractory pediatric epilepsy. Recent research has shown that it has neuroprotective properties and can improve quality of life in patients with various neurological disorders such as multiple sclerosis and Alzheimer's disease. The major ketone bodies BHB and ACA are believed to play a key role in these beneficial effects through specific inflammatory proteins, transcription factors, and other mechanisms.